{"id":45986,"date":"2026-02-12T14:11:20","date_gmt":"2026-02-12T12:11:20","guid":{"rendered":"https:\/\/purama.lt\/?p=45986"},"modified":"2026-04-22T14:17:25","modified_gmt":"2026-04-22T12:17:25","slug":"nmn-miti","status":"publish","type":"post","link":"https:\/\/purama.lt\/lv\/nmn-mitai\/","title":{"rendered":"NMN m\u012bti: 7 popul\u0101r\u0101kie apgalvojumi un pier\u0101d\u012bjumi par tiem"},"content":{"rendered":"<p>NMN (nikot\u012bnam\u012bda mononukleot\u012bds) bie\u017ei tiek piemin\u0113ts l\u012bdz\u0101s NAD+ biolo\u0123ijas un ilgm\u016b\u017e\u012bbas t\u0113m\u0101m. Tom\u0113r NMN st\u0101sts publiskaj\u0101 telp\u0101 bie\u017ei vien tiek vienk\u0101r\u0161ots, da\u017eviet izsakot p\u0101r\u0101k pla\u0161us sol\u012bjumus, bet citviet kategoriski noliedzot. Tas parasti notiek, kad <strong>bio\u0137\u012bmiskie r\u0101d\u012bt\u0101ji<\/strong> (piem\u0113ram, NAD+ un t\u0101 metabol\u012bti) tiek sajaukti ar <strong>re\u0101las vesel\u012bbas vai funkciju izmai\u0146as.<\/strong> (piem\u0113ram, vielmai\u0146as parametri, fizisk\u0101s slodzes sp\u0113jas, musku\u013cu funkcija vai citi praktiski svar\u012bgi m\u0113r\u012bjumi).<\/p>\n\n\n\n<p>\u0160aj\u0101 rakst\u0101 ir sniegti 7 visbie\u017e\u0101k atk\u0101rtotie apgalvojumi par NMN un tie ir skaidri izskaidroti, <strong>ko r\u0101da cilv\u0113ku dati<\/strong>, k\u0101das ir p\u0113tniec\u012bbas robe\u017eas un kur parasti s\u0101kas interpret\u0101cijas k\u013c\u016bdas. Teksts ir informat\u012bvs.<\/p>\n\n\n\n<p><strong>Vair\u0101k par NMN:<\/strong> Pla\u0161\u0101ku kontekstu (pamatj\u0113dzieni, NAD+ lo\u0123ika, kvalit\u0101tes nov\u0113rt\u0113\u0161anas krit\u0113riji) sk. <a href=\"https:\/\/purama.lt\/lv\/nmn-celvedis\/\">Viss par NMN: piln\u012bgs ce\u013cvedis<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">M\u012bts 1: \u201eNMN ir jaun\u012bbas eliks\u012brs\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> NMN tiek pasniegts k\u0101 l\u012bdzeklis \u201epal\u0113nin\u0101t noveco\u0161anu\u201c vai \u201eatjaunot\u201c.<\/p>\n\n\n\n<p><strong>Pier\u0101d\u012bjumi liecina:<\/strong> Kl\u012bniskos p\u0113t\u012bjumos ar cilv\u0113kiem NMN parasti nov\u0113rt\u0113, izmantojot starpposma biolo\u0123iju: asins vai \u0161\u016bnu metabol\u012btus, NAD+ un ar NAD+ saist\u012bto savienojumu izmai\u0146as, k\u0101 ar\u012b dro\u0161uma\/toler\u0113jam\u012bbas uzraudz\u012bbu. Viens no bie\u017e\u0101k cit\u0113tajiem p\u0113t\u012bjumiem - randomiz\u0113ts, dubultmask\u0113ts, placebo kontrol\u0113ts p\u0113t\u012bjums gados vec\u0101ku v\u012brie\u0161u grup\u0101 - par\u0101d\u012bja, ka NMN ilgsto\u0161a lieto\u0161ana tika labi panesta un saist\u012bta ar NAD+ un t\u0101 metabol\u012btu l\u012bme\u0146a izmai\u0146\u0101m asin\u012bs. Tom\u0113r \u0161\u0101da veida rezult\u0101ti nav vien\u0101di ar pier\u0101d\u012btiem ilgtermi\u0146a ilgm\u016b\u017e\u012bbas ieguvumiem cilv\u0113kiem.<\/p>\n\n\n\n<p><strong>Avots:<\/strong> \u201eHroniska nikot\u012bnam\u012bda mononukleot\u012bda lieto\u0161ana...\u201c (Nature Aging, 2022). <a href=\"https:\/\/www.nature.com\/articles\/s41514-022-00084-z\" target=\"_blank\" rel=\"noreferrer noopener\">Skat\u012bt publik\u0101ciju<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> NMN ir savienojums ar interesantiem bio\u0137\u012bmiskiem sign\u0101liem, kas pa\u0161laik tiek p\u0113t\u012bts, ta\u010du apgalvojums par \u201ejaun\u012bbas eliks\u012bru\u201c ir p\u0101r\u0101k pla\u0161s, jo tas ir balst\u012bts uz to, ko auditorija v\u0113las dzird\u0113t, nevis uz to, ko faktiski pier\u0101da p\u0113t\u012bjumi ar cilv\u0113kiem.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2. m\u012bts: \u201eJa NMN palielina NAD+, tas autom\u0101tiski uzlabo pa\u0161saj\u016btu\u201c.\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> Ja NAD+ (vai ar to saist\u012btie r\u0101d\u012bt\u0101ji) palielin\u0101sies, ikviena cilv\u0113ka labkl\u0101j\u012bbai vajadz\u0113tu uzlaboties.<\/p>\n\n\n\n<p><strong>Pier\u0101d\u012bjumi liecina:<\/strong> Da\u017ei p\u0113t\u012bjumi liecina par bio\u0137\u012bmisku \u201em\u0113r\u0137a iesaist\u012b\u0161anu\u201c, t. i., NAD+ l\u012bme\u0146a vai metabol\u012btu izmai\u0146\u0101m. Tom\u0113r kl\u012bniskie rezult\u0101ti var at\u0161\u0137irties: da\u017eos p\u0113t\u012bjumos m\u0113ra vair\u0101k biolo\u0123isko parametru, citos - vair\u0101k funkcion\u0101lo parametru, at\u0161\u0137iras p\u0113t\u012bjumu ilgums, popul\u0101cija (vecums, metaboliskais st\u0101voklis) un da\u017ek\u0101rt ar\u012b m\u0113r\u012b\u0161anas metodes. Piem\u0113ram, randomiz\u0113ts, daudzcentru, dubultmask\u0113ts, placebo kontrol\u0113ts p\u0113t\u012bjums ar veseliem pusm\u016b\u017ea dal\u012bbniekiem par\u0101d\u012bja b\u016btisku NAD parametru palielin\u0101\u0161anos NMN grup\u0101s un labu panesam\u012bbu, bet da\u017ei metaboliskie parametri (piem\u0113ram, HOMA-IR) neuzr\u0101d\u012bja b\u016btiskas at\u0161\u0137ir\u012bbas no placebo p\u0113t\u012bjuma laik\u0101.<\/p>\n\n\n\n<p><strong>Avoti:<\/strong> Yi et al., 2023 (PubMed ieraksts). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36482258\/\" target=\"_blank\" rel=\"noreferrer noopener\">Skat\u012bt kopsavilkumu vietn\u0113 PubMed<\/a>. Pilns teksts (PMC): <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9735188\/\" target=\"_blank\" rel=\"noreferrer noopener\">Skat\u012bt pilnu tekstu<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> Bio\u0137\u012bmisk\u0101s p\u0101rmai\u0146as ir svar\u012bgas, ta\u010du t\u0101s autom\u0101tiski negarant\u0113, ka ikdienas pa\u0161saj\u016bta vai funkcijas main\u012bsies tikpat skaidri. Visdro\u0161\u0101kie secin\u0101jumi tiek izdar\u012bti, ja p\u0113t\u012bjumos biomar\u0137ieri konsekventi tiek sasaist\u012bti ar noz\u012bm\u012bgiem funkcion\u0101liem rezult\u0101tiem.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3. m\u012bts: \u201eNMN ir izr\u0101d\u012bjies p\u0101r\u0101ks, jo tas ir \u2018tuv\u0101ks\u2019 NAD+\u201c.\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> Bie\u017ei tiek atk\u0101rtota vienk\u0101r\u0161ota sh\u0113ma (NR \u2192 NMN \u2192 NAD+), no kuras izriet, ka NMN vajadz\u0113tu b\u016bt lab\u0101kai par citiem NAD+ prekursoriem.<\/p>\n\n\n\n<p><strong>Pier\u0101d\u012bjumi liecina:<\/strong> Biolo\u0123ij\u0101 \u201ece\u013cvedis\u201c vien neatbild uz jaut\u0101jumu, k\u0101 savienojums darbojas cilv\u0113ka organism\u0101. Svar\u012bga ir audu izplat\u012bba, metabolisms, stabilit\u0101te, m\u0113r\u012b\u0161anas metodes un anal\u012b\u017eu dizains. Kad runa ir par sal\u012bdzin\u0101jumiem, vislab\u0101k ir atsaukties uz to, ko p\u0113t\u012bjumos faktiski m\u0113ra, un izvair\u012bties no absol\u016btu apgalvojumu izteik\u0161anas. T\u0101p\u0113c, ja v\u0113laties struktur\u0113tu sal\u012bdzin\u0101jumu, ir dabiski atsaukties uz atsevi\u0161\u0137u sal\u012bdzin\u0101\u0161anas rakstu.<\/p>\n\n\n\n<p><strong>Saist\u012bts raksts:<\/strong> <a href=\"https:\/\/purama.lt\/lv\/nmn-vs-nr\/\">NMN pret NR: NAD+ prekursoru sal\u012bdzin\u0101jums<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> \u201eArguments \u201ctuv\u0101k NAD+\" pats par sevi nav pier\u0101d\u012bjums. T\u0101 var b\u016bt hipot\u0113ze, bet secin\u0101jumam j\u0101b\u016bt balst\u012btam uz cilv\u0113ku datiem un skaidriem m\u0113r\u012bjumiem.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4. m\u012bts: \u201eNMN ir piln\u012bgi dro\u0161s, jo tas ir dabiska viela\u201c.\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> \u201edab\u012bgs\u201c bie\u017ei (k\u013c\u016bdaini) tiek piel\u012bdzin\u0101ts \u201epiln\u012bgi dro\u0161s\u201c.<\/p>\n\n\n\n<p><strong>Pier\u0101d\u012bjumi liecina:<\/strong> dro\u0161umu nov\u0113rt\u0113, izmantojot kl\u012bnisk\u0101 p\u0113t\u012bjuma datus: nev\u0113lamie notikumi, laboratoriskie un kl\u012bniskie main\u012bgie lielumi, p\u0113t\u012bjuma ilgums un popul\u0101cija. Iepriek\u0161 min\u0113taj\u0101 p\u0113t\u012bjum\u0101, ko veica Yi un l\u012bdzautori, tika aprakst\u012bta laba panesam\u012bba un netika zi\u0146ots par dro\u0161\u012bbas probl\u0113m\u0101m attiec\u012bb\u0101 uz nov\u0113rotajiem parametriem p\u0113t\u012bjuma laik\u0101. Cit\u0101 piem\u0113r\u0101, p\u0113t\u012bjum\u0101 Nature Aging, kas veikts ar gados vec\u0101kiem v\u012brie\u0161iem, ar\u012b tika zi\u0146ots par labu panesam\u012bbu un netika nov\u0113rotas b\u016btiskas nev\u0113lamas blakuspar\u0101d\u012bbas attiec\u012bb\u0101 uz nov\u0113rotajiem parametriem.<\/p>\n\n\n\n<p><strong>Avoti:<\/strong> Yi et al, 2023 (PubMed\/PMC). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36482258\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9735188\/\" target=\"_blank\" rel=\"noreferrer noopener\">PMC<\/a>. Igarashi et al, 2022 (Nature Aging). <a href=\"https:\/\/www.nature.com\/articles\/s41514-022-00084-z\" target=\"_blank\" rel=\"noreferrer noopener\">Publik\u0101cija<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> P\u0113t\u012bjumi ar cilv\u0113kiem sniedz noder\u012bgu priek\u0161statu par dro\u0161\u012bbu vair\u0101ku ned\u0113\u013cu vai m\u0113ne\u0161u laik\u0101, ta\u010du \u201epiln\u012bgi dro\u0161s ikvienam un visu laiku\u201c ir p\u0101r\u0101k pla\u0161s j\u0113dziens. Ilgtermi\u0146a riski, z\u0101\u013cu mijiedarb\u012bba un specifiskas iedz\u012bvot\u0101ju grupas (piem\u0113ram, hroniskas slim\u012bbas) prasa atsevi\u0161\u0137u, r\u016bp\u012bg\u0101ku nov\u0113rt\u0113jumu.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5. m\u012bts: \u201eNMN p\u0113t\u012bjumi jau ir pier\u0101d\u012bju\u0161i ilgtermi\u0146a ieguvumus vesel\u012bbai\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> jo \u201eir pieejami p\u0113t\u012bjumi\u201c, secin\u0101jums ir t\u0101ds, ka ilgtermi\u0146a ieguvumi jau ir pier\u0101d\u012bti.<\/p>\n\n\n\n<p><strong>Pier\u0101d\u012bjumi liecina:<\/strong> Da\u017eos p\u0113t\u012bjumos ar cilv\u0113kiem apl\u016bkoti metaboliskie vai funkcion\u0101lie aspekti, bet ilgm\u016b\u017e\u012bbas kontekst\u0101 svar\u012bgs jaut\u0101jums ir laika izv\u0113le un rezult\u0101ti. Piem\u0113ram, Yoshino un l\u012bdzautoru veiktaj\u0101 dubultmask\u0113t\u0101, placebo kontrol\u0113taj\u0101 10 ned\u0113\u013cu ilgaj\u0101 p\u0113t\u012bjum\u0101 ar sieviet\u0113m p\u0113c menopauzes (ar prediab\u0113tu un lieko svaru\/aptauko\u0161anos) tika v\u0113rt\u0113ta vielmai\u0146as funkcija un musku\u013cu insul\u012bns. \u0160\u0101di p\u0113t\u012bjumi ir svar\u012bgi, bet tajos tiek v\u0113rt\u0113ti konkr\u0113ti parametri konkr\u0113t\u0101 popul\u0101cij\u0101, nevis \u201eilgm\u016b\u017e\u012bba\u201c k\u0101 izn\u0101kums.<\/p>\n\n\n\n<p><strong>Avots:<\/strong> Yoshino et al, 2021 (Science). <a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.abe9985\" target=\"_blank\" rel=\"noreferrer noopener\">Skat\u012bt publik\u0101ciju<\/a>. Pilns teksts (PMC): <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8550608\/\" target=\"_blank\" rel=\"noreferrer noopener\">Skat\u012bt pilnu tekstu<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> NMN kl\u012bniskie p\u0113t\u012bjumi ir augo\u0161a joma, ta\u010du \u201epier\u0101d\u012bts ilgtermi\u0146a ieguvums\u201c ir stingrs apgalvojums, kas parasti prasa ilg\u0101kus, apjom\u012bg\u0101kus un uz rezult\u0101tiem orient\u0113tus p\u0113t\u012bjumus. Pa\u0161laik daudz ticam\u0101ks formul\u0113jums ir t\u0101ds, ka p\u0113t\u012bjumi ar cilv\u0113kiem liecina par bio\u0137\u012bmisko iedarb\u012bbu, bet funkcion\u0101lie rezult\u0101ti ir main\u012bgi un atkar\u012bgi no konteksta.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">6. m\u012bts: \u201eVisi NMN produkti ir vien\u0101di - svar\u012bgs ir numurs uz eti\u0137etes.\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> \u201eNMN ir vissvar\u012bg\u0101kais\u201c; kvalit\u0101tes at\u0161\u0137ir\u012bbas tiek uzskat\u012btas par sekund\u0101r\u0101m.<\/p>\n\n\n\n<p><strong>Ko r\u0101da prakse:<\/strong> Uztura bag\u0101tin\u0101t\u0101ju tirg\u016b kvalit\u0101te bie\u017ei vien ir iz\u0161\u0137iro\u0161s faktors, jo \u012bpa\u0161i, ja runa ir par savienojumiem, kuriem j\u0101b\u016bt stabiliem un ar nor\u0101d\u012bto t\u012br\u012bbu. Profesion\u0101l\u0101 nov\u0113rt\u0113juma pamat\u0101 parasti ir dokument\u0101cija un izsekojam\u012bba:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>COA (anal\u012bzes sertifik\u0101ts):<\/strong> vai ir sniegta katras partijas anal\u012bze, nor\u0101dot t\u012br\u012bbu un metodolo\u0123iju.<\/li>\n\n\n\n<li><strong>Puses numurs:<\/strong> vai dokuments patie\u0161\u0101m ir saist\u012bts ar p\u0101rdodamo partiju.<\/li>\n\n\n\n<li><strong>Neatkar\u012bga anal\u012bze:<\/strong> tre\u0161\u0101s valsts laboratorijas apstiprin\u0101jums, ja t\u0101ds ir pieejams.<\/li>\n\n\n\n<li><strong>Izsekojam\u012bba:<\/strong> skaidra inform\u0101cija par produkcijas\/partijas izcelsmi.<\/li>\n<\/ul>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> Uz eti\u0137etes nor\u0101d\u012btais numurs vien neapraksta produkta uzticam\u012bbu. Kvalit\u0101te j\u0101nov\u0113rt\u0113, izmantojot dokument\u0101ciju, izsekojam\u012bbu un p\u0101rredzam\u012bbu.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">M\u012bts Nr. 7: \u201eNormat\u012bvais statuss visur ir vien\u0101ds, t\u0101p\u0113c par to nav v\u0113rts dom\u0101t.\u201c<\/h2>\n\n\n\n<p><strong>Pras\u012bba:<\/strong> Tiek pie\u0146emts, ka, ja NMN ir popul\u0101rs vien\u0101 tirg\u016b, t\u0101 regulat\u012bvais statuss autom\u0101tiski ir identisks ar\u012b citur.<\/p>\n\n\n\n<p><strong>K\u0101di realit\u0101tes \u0161ovi:<\/strong> tiesiskais regul\u0113jums da\u017e\u0101dos re\u0123ionos ir at\u0161\u0137ir\u012bgs. ES jaut\u0101jumi, kas saist\u012bti ar jaunu p\u0101rtikas produktu statusu, tiek risin\u0101ti ES procesos un dokumentos. T\u0101p\u0113c, v\u0113rt\u0113jot \u0161o tematu, ir svar\u012bgi atsaukties uz ofici\u0101liem avotiem un izvair\u012bties no vienk\u0101r\u0161ojumiem.<\/p>\n\n\n\n<p><strong>Piez\u012bme:<\/strong> ja j\u016bs interes\u0113 NAD+ priek\u0161g\u0101j\u0113ju sal\u012bdzin\u0101jums (ieskaitot kontekstu), skatiet. <a href=\"https:\/\/purama.lt\/lv\/nmn-vs-nr\/\">NMN pret NR: NAD+ prekursoru sal\u012bdzin\u0101jums<\/a>.<\/p>\n\n\n\n<p><strong>Secin\u0101jums:<\/strong> regulat\u012bvais konteksts ir atsevi\u0161\u0137s temats, ko ir v\u0113rts izp\u0113t\u012bt, pamatojoties uz dokumentiem, nevis visp\u0101r\u012bgiem apgalvojumiem.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Kopsavilkums<\/h2>\n\n\n\n<p>\u2714\ufe0f Kvalit\u0101tes nov\u0113rt\u0113\u0161anai j\u0101balst\u0101s uz COA, izsekojam\u012bbu un p\u0101rredzam\u012bbu, nevis tikai uz deklar\u0101cij\u0101m.<br>\u2714\ufe0f P\u0113t\u012bjumos ar cilv\u0113kiem NMN bie\u017ei ir saist\u012bts ar NAD+ un saist\u012bto metabol\u012btu izmai\u0146\u0101m.<br>\u2714\ufe0f Funkcion\u0101lie rezult\u0101ti ir atkar\u012bgi no p\u0113t\u0101m\u0101s popul\u0101cijas, p\u0113t\u012bjuma ilguma un v\u0113rt\u0113jamajiem raksturlielumiem, t\u0101p\u0113c visp\u0101r\u0113jie secin\u0101jumi ir piesardz\u012bgi.<br>\u2714\ufe0f Parasti p\u0113t\u012bjumos ar cilv\u0113kiem p\u0113t\u012bjuma laik\u0101 dro\u0161\u012bbu un panesam\u012bbu raksturo labv\u0113l\u012bgi, ta\u010du tas nav absol\u016bts apgalvojums vis\u0101m situ\u0101cij\u0101m.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">BIE\u017d\u0100K UZDOTIE JAUT\u0100JUMI<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list\">\n<div id=\"faq-question-1770898406759\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">1) Vai NMN iedarb\u012bba uz cilv\u0113kiem ir \u201epier\u0101d\u012bta\u201c?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>P\u0113t\u012bjumi ar cilv\u0113kiem liecina par ar NAD+ saist\u012bto mar\u0137ieru bio\u0137\u012bmisk\u0101m izmai\u0146\u0101m, bet kl\u012bniskie rezult\u0101ti ir atkar\u012bgi no p\u0113t\u012bjuma pl\u0101na, popul\u0101cijas un ilguma. T\u0101p\u0113c vislab\u0101k ir run\u0101t par konkr\u0113tu p\u0113t\u012bjumu rezult\u0101tiem, nevis par univers\u0101lu secin\u0101jumu visiem gad\u012bjumiem.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1770898428253\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">2) Vai NMN ir p\u0113t\u012bts nejau\u0161in\u0101tos, dubultaklos p\u0113t\u012bjumos?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>J\u0101. Ir public\u0113ti randomiz\u0113ti, dubultmask\u0113ti, placebo kontrol\u0113ti p\u0113t\u012bjumi, piem\u0113ram, Nature Aging publik\u0101cija, kas attiecas uz vec\u0101ku v\u012brie\u0161u grupu. <\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1770898644363\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">3) Vai NMN dro\u0161\u012bba p\u0113t\u012bjumos ar cilv\u0113kiem ir aprakst\u012bta labv\u0113l\u012bgi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Da\u017eos kl\u012bniskajos p\u0113t\u012bjumos ir aprakst\u012bta laba panesam\u012bba un nav dokument\u0113tas b\u016btiskas dro\u0161\u012bbas probl\u0113mas p\u0113t\u012bjuma period\u0101 attiec\u012bb\u0101 uz nev\u0113lamiem notikumiem un laboratoriskajiem parametriem.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1770898682439\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">4) Uz k\u0101da pamata tiek nov\u0113rt\u0113ta produkta uzticam\u012bba?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Praks\u0113 svar\u012bga ir dokument\u0101cija (COA), partijas numurs, izsekojam\u012bba un skaidri t\u012br\u012bbas r\u0101d\u012bt\u0101ji. Tas \u013cauj produktu v\u0113rt\u0113t p\u0113c p\u0101rbaud\u0101miem krit\u0113rijiem, nevis p\u0113c sol\u012bjumiem.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>NMN (nikotinamido mononukleotidas) da\u017enai minimas \u0161alia NAD+ biologijos ir ilgaam\u017ei\u0161kumo tem\u0173. Ta\u010diau vie\u0161ojoje erdv\u0117je NMN istorija neretai supaprastinama: vienur pateikiami per plat\u016bs pa\u017eadai, kitur \u2013 per kategori\u0161ki paneigimai. Da\u017eniausiai taip nutinka tada, kai biocheminiai rodikliai (pvz., NAD+ ir jo metabolitai) painiojami su realiais sveikatos ar funkcijos poky\u010diais (pvz., metaboliniais rodikliais, fiziniu paj\u0117gumu, raumen\u0173 funkcija ar [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":45995,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[310],"tags":[],"class_list":["post-45986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ilgaamziskumo-gidas"],"acf":[],"_links":{"self":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts\/45986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/comments?post=45986"}],"version-history":[{"count":0,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts\/45986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/media\/45995"}],"wp:attachment":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/media?parent=45986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/categories?post=45986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/tags?post=45986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}